Protagenic Therapeutics (PTIX) had the highest return in January 2012 by a US stock, returning 790.2%.

ASSET	MONTH	% RETURN
Protagenic Therapeutics (PTIX)	January 2012	790.24%
Optex Systems Holdings, Inc Common Stock (OPXS)	January 2012	300%
Better Choice (BTTR)	January 2012	200%
Byrna Technologies (BYRN)	January 2012	200%
Supercom (SPCB)	January 2012	200%
Quantum Computing (QUBT)	January 2012	177.78%
Paltalk (PALT)	January 2012	164.52%
FlexShopper (FPAY)	January 2012	163.64%
QXO (QXO)	January 2012	150%
Alerus Financial (ALRS)	January 2012	135.29%
CASI Pharmaceuticals (CASI)	January 2012	129.17%
INVO Bioscience (INVO)	January 2012	127.27%
NAYA Biosciences (NAYA)	January 2012	127.27%
AIM ImmunoTech (AIM)	January 2012	120%
Lee Enterprises (LEE)	January 2012	84.72%
Fluent (FLNT)	January 2012	84.63%
NioCorp Developments Ltd Common Stock (NB)	January 2012	83.31%
Amicus Therapeutics (FOLD)	January 2012	83.1%
Celldex Therapeutics (CLDX)	January 2012	78.87%
Chromadex (CDXC)	January 2012	76.92%
Hudson Technologies (HDSN)	January 2012	76.39%
Talphera (TLPH)	January 2012	71.88%
Netflix (NFLX)	January 2012	71.03%
Profire Ene (PFIE)	January 2012	68.92%
Opus Genetics (IRD)	January 2012	68.42%